UK NEQAS CPT

Name

UK NEQAS CPT

Website

https://ukneqascpt.org.uk

Company type

Private

Headcount range

11–50 employees

Short description

UK NEQAS CPT is a UK-based non-profit organization with 18 employees, headquartered in Newcastle upon Tyne. Its name indicates affiliation with the UK National External Quality Assessment Service for Clinical Pharmacology and Therapeutics, a clinical laboratory proficiency testing scheme.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Quality Assessment

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)

akta.pro secondary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• External quality assessment
• Proficiency testing services
• Cellular pathology EQA
• Laboratory quality assurance
• Diagnostic accuracy schemes

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Core offering

UK NEQAS CPT provides external quality assessment (EQA) and proficiency testing schemes for cellular pathology laboratories in the UK. Its core service is the design, distribution, and independent evaluation of standardized testing materials so that diagnostic laboratories can benchmark their performance against peers and meet accreditation requirements.

Differentiator

Problem solved

Functional benefit

Products and services

• UK NEQAS CPT Cellular Pathology Proficiency Testing Schemes Subscription-based external quality assessment (EQA) schemes in which cellular pathology laboratories receive standardized testing materials, submit diagnostic results, and receive independent peer-comparison performance reports to support accreditation and quality assurance. Intended for NHS and private cellular pathology / histopathology laboratories in the United Kingdom.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Qualisure (Labquality): Finnish-based EQA and quality assurance provider for clinical laboratories, with expanding scheme offerings in pathology. Comparable in scheme model and European participant base to UK NEQAS CPT.
• UK National External Quality Assessment Service for Molecular Genetics: Sibling UK NEQAS scheme focused on molecular genetics; comparable in operating model and non-profit structure, but targets a different pathology sub-discipline than UK NEQAS CPT.

Direct peers

• Canadian Immunohistochemistry Quality Control (CIQC): Canadian EQA programme focused on immunohistochemistry and in situ hybridisation, mirroring UK NEQAS CPT's focus on cellular pathology techniques. Highly comparable in scope and target participants.
• INSTAND e.V. German-based scientific society providing external quality assessment schemes in pathology and laboratory medicine. Comparable to UK NEQAS CPT as a non-profit, scheme-based EQA provider serving European laboratories.
• UK NEQAS for Histopathology: Closest direct peer under the UK NEQAS umbrella, providing EQA for histopathology laboratories. Highly comparable in scheme design, target participants, and governance model to UK NEQAS CPT.
• NordiQC: Nordic Immunohistochemical Quality Control, a leading international EQA provider for immunohistochemistry and related cellular pathology techniques. Directly comparable in mission and scheme structure to UK NEQAS CPT.

Regional players

• Stichting Kwaliteitsbewaking Zorg (SKML): Dutch foundation coordinating EQA programmes across medical laboratories, including histopathology. Operates a comparable scheme-based, non-profit model but primarily serves the Netherlands and adjacent markets.
• RCPAQAP: Royal College of Pathologists of Australasia Quality Assurance Programs; a major EQA provider across cellular pathology, genomics, and other disciplines. Comparable in scheme design but primarily serves the Asia-Pacific region.

Broad incumbents

• UK NEQAS (parent organisation): The umbrella organisation for UK NEQAS schemes, including CPT. Operates a broader portfolio of EQA programmes across multiple pathology disciplines under a single, internationally recognised quality-assessment brand.
• College of American Pathologists (CAP): Operates extensive laboratory proficiency testing and accreditation programmes globally. Overlaps with UK NEQAS CPT in providing EQA for cellular pathology and adjacent disciplines, but at much larger scale.

Market position

Customer concentration

• LinkedInlinkedin.com/company/uk-neqas-cpt

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UK NEQAS CPT